EUVIMEDEUVIMED entdecken
Crossref

3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3

Bindiya Ellathuparambil Saidumohamed, Tina Kollannoor Johny, Anju Thoppil Raveendran, Unnikrishanan Babukuttan Sheela, Maya Sreeranganathan, Raghul Subin Sasidharan, Sarita Ganapathy Bhat

Re:GEN Open · 2022

DOI: 10.1089/regen.2021.0041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Re:GEN Open, 2022. Verfasst von Bindiya Ellathuparambil Saidumohamed und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the world of intense usage of antibiotics, the emergence of antimicrobial resistance necessitates research on alternative forms of antibiotics, antimicrobial peptides (AMPs), which are least known to induce resistance. The partial sequence of bacteriocin BaCf3, produced by marine Bacillus amyloliquefaciens BTSS3, derived from Matrix Assisted Laser Desorption Ionisation - Time of Flight Tandem Mass Spectroscopy (MALDI-ToF MS/MS) data was analyzed for amino acid composition and modelled in silico using TrRosetta. The mechanism of action of BaCf3 was studied in vitro on B. circulans NCIM2107 cell wall using microscopic techniques, such as confocal laser scanning microscopy, scanning electron microscopy, and high resolution transmission electron microscopy. Docking studies with cancer markers, glucose transporter protein, and mesenchymal-epithelial transition factor (MET) receptor tyrosine kinase were also conducted. BaCf3 was found to be rich in glycine and hydrophobic in nature, a characteristic property of cell wall acting AMPs. The structure of BaCf3 obtained from TrRosetta had antiparallel b-sheets resembling Laterosporulin. The bacteriocin BaCf3 has been found to act on the cell membrane of opportunistic pathogen Bacillus circulans, causing permeabilization and pore formation by dissipating the membrane potential. The microscopic examination also proved the mode of action of BaCf3 as cell wall acting. In silico docking studies with anticancer target proved that bacteriocin BaCf3 is also a possible anticancer drug candidate. In vitro anticancer assays such as 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and acridine orange/ethidium bromide dual staining on lung carcinorma cell line A549 further prove the anticancer activity of the bacteriocin.

Zitieren

APA

Saidumohamed, B. E., Johny, T. K., Raveendran, A. T., Sheela, U. B., Sreeranganathan, M., Sasidharan, R. S., & Bhat, S. G. (2022). 3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3. Re:GEN Open. https://doi.org/10.1089/regen.2021.0041

Vancouver

Saidumohamed BE, Johny TK, Raveendran AT, Sheela UB, Sreeranganathan M, Sasidharan RS, et al. 3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3. Re:GEN Open. 2022. doi:10.1089/regen.2021.0041

BibTeX
@article{Saidumohamed2022,
  author = {Saidumohamed, Bindiya Ellathuparambil and Johny, Tina Kollannoor and Raveendran, Anju Thoppil and Sheela, Unnikrishanan Babukuttan and Sreeranganathan, Maya and Sasidharan, Raghul Subin and Bhat, Sarita Ganapathy},
  title = {3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3},
  journal = {Re:GEN Open},
  year = {2022},
  doi = {10.1089/regen.2021.0041}
}
Kostenlos starten →